rSPA - Native Recombinant Staphylococcal Protein A Ligand

rSPA –Native Recombinant Staphylococcal Protein A Ligand – is the most advanced non-mutant Protein A ligand available from Repligen. The combination of performance and purity to native Protein A and outstanding economics and supply chain security, makes rSPA the automatic first choice for all new Protein A ligand applications.

  • Contains the same amino acid sequence and molecular mass as the native Protein A sourced from S. aureus
  • Manufactured with animal-free materials
Protein A Ligand Types CharacteristicsLegacy Native Staphylococcal srPA50 rSPA
IgG BindingBinds 3 IgG Isotypes Binds 3 IgG Isotypes Binds 3 IgG Isotypes
Binding Capacity~50mg/mL hIgH ~50mg/mL hIgH ~50mg/mL hIgH
Purity> 95% by SEC ≥ 98% by rPhase C4 > 95% by SEC
Animal Free Yes Yes Yes
Fermentation Organism S. aureus extractioon E. coli Fermentation E. coli Fermentation
Endotoxin≤ 1.0 Eu/mg ≤ 0.5 Eu/mg ≤ 1.0 Eu/mg
Sequence Natural S. aureus N-terminus, beta-Glucuronidase Natural S. aureus
Features Animal Free, In Approved processes Animal Free, In Approved processes Animal Free, Exact native mimetic, Identical amino acids
Selection Guide User Considersations Legacy products Original rPA, Legacy products Ligand of choice for all new processes, Highly cost effective

Native Protein A Ligand

Native Protein A is a purification ligand used to isolate IgG from crude protein mixtures.  It binds with high affinity to the Fc region of IgG's. When immobilized on a matrix, e.g; Sepharose, Protein A (native) can be used to isolate IgG from crude protein mixtures.

Native Protein A meets the strictest demands of drug manufacturers in terms of purity, reproducibility, binding capacity, specificity and other key measures critical to the quality of downstream processes.

  • Reliable performance: Fc specific binding to IgG
  • Guaranteed purity: > 95% purity by SEC
  • Activity: > 95% IgG-binding activity
  • Not purified by hIgG affinity
  • Produced according to cGMP